AJ

Alkakumari Jayprakash Mishra

Active Director Director DIN 10479413
DIN 10479413 First appointment Jan 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Alkakumari Jayprakash Mishra

Data last updated:

Alkakumari Jayprakash Mishra is a Director at Novum Therapeutics Private Limited (since 2024). The company operates in Healthcare.

DIN 10479413
Primary Designation Director
Industry Healthcare
First Appointment 25 Jan 2024
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novum Therapeutics Private Limited U85310GJ2019PTC111756
Director25 Jan 20242019Active

Board colleagues of Alkakumari Jayprakash Mishra

NameDINCompanyDesignation
Jayprakash Mishra03461758Novum Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novum Therapeutics Private Limited
Premium access

Shareholding and investment profile for Alkakumari Jayprakash Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alkakumari Jayprakash Mishra

Alkakumari Jayprakash Mishra currently holds 1 directorship: Novum Therapeutics Private Limited (Director, since 25 Jan 2024).

Alkakumari Jayprakash Mishra was first appointed on 25 Jan 2024 as Director at Novum Therapeutics Private Limited.

The current boards of Alkakumari Jayprakash Mishra's companies include Jayprakash Mishra (Novum Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available